SUWAX
Price
$37.44
Change
-$0.02 (-0.05%)
Updated
Nov 13 closing price
VTSAX
Price
$144.14
Change
-$0.09 (-0.06%)
Updated
Nov 13 closing price
Ad is loading...

SUWAX vs VTSAX

Header iconSUWAX vs VTSAX Comparison
Open Charts SUWAX vs VTSAXBanner chart's image
DWS Core Equity A
Price$37.44
Change-$0.02 (-0.05%)
VolumeN/A
CapitalizationN/A
Vanguard Total Stock Mkt Idx Adm
Price$144.14
Change-$0.09 (-0.06%)
VolumeN/A
CapitalizationN/A
SUWAX vs VTSAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
SUWAX vs. VTSAX commentary
Nov 14, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SUWAX is a StrongBuy and VTSAX is a Buy.

FUNDAMENTALS
Fundamentals
VTSAX has more cash in the bank: 1.73T vs. SUWAX (4.71B). VTSAX pays higher dividends than SUWAX: VTSAX (1.35) vs SUWAX (0.58). SUWAX was incepted earlier than VTSAX: SUWAX (25 years) vs VTSAX (24 years). SUWAX is a more actively managed with annual turnover of: 33.00 vs. VTSAX (2.00). SUWAX has a lower initial minimum investment than VTSAX: SUWAX (1000) vs VTSAX (3000). VTSAX annual gain was more profitable for investors over the last year : 33.39 vs. SUWAX (26.40). VTSAX return over 5 years is better than : 87.46 vs. SUWAX (38.53).
SUWAXVTSAXSUWAX / VTSAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence25 years24 years-
Gain YTD23.14024.89193%
Front LoadN/AN/A-
Min. Initial Investment1000300033%
Min. Initial Investment IRAN/AN/A-
Net Assets4.71B1.73T0%
Annual Yield % from dividends0.581.3543%
Returns for 1 year26.4033.3979%
Returns for 3 years2.6522.8212%
Returns for 5 years38.5387.4644%
Returns for 10 years59.51194.0731%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VERX50.580.83
+1.67%
Vertex
IT551.801.14
+0.21%
Gartner
PDFS31.88-0.95
-2.89%
PDF Solutions
KMDA6.06-0.21
-3.35%
Kamada Ltd
VRCA0.84-0.08
-8.37%
Verrica Pharmaceuticals